ロード中...
Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.
Sparfloxacin, a new fluorinated quinolone, exhibits higher in vitro activity against pneumococci than do ciprofloxacin and ofloxacin. Since up to 30% of cases of pneumococcal pneumonia are associated with bacteremia, and since an increasing percentage of pneumococci are resistant against penicillin,...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC163197/ https://ncbi.nlm.nih.gov/pubmed/8851610 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|